Published in Cancer on May 15, 2002
Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations. Fam Cancer (2004) 0.90
The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility. Fam Cancer (2004) 0.83
Genetic factors and colorectal cancer in Ashkenazi Jews. Fam Cancer (2004) 0.80
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes. Hered Cancer Clin Pract (2015) 0.79
Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects. Fam Cancer (2016) 0.75
Colonic Adenomas Do Not Cosegregate with the I1307K APC Missense Mutation in an Israeli Non-Ashkenazi Family. Dig Dis Sci (2005) 0.75
Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes. Nat Genet (2010) 3.66
Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell (2007) 2.87
Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn (2013) 2.87
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology (2013) 2.64
Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases. JAMA (2007) 2.51
A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet (2002) 2.24
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Mov Disord (2013) 2.01
The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol (2003) 2.00
Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A (2006) 1.99
Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int (2006) 1.96
Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol (2009) 1.53
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
Array-based comparative genome hybridization in clinical genetics. Pediatr Res (2006) 1.49
False-positive results using a Gaucher diagnostic kit--RecTL and N370S. Mol Genet Metab (2010) 1.48
Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenat Diagn (2012) 1.45
Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res (2002) 1.40
Central role of alpha7 nicotinic receptor in differentiation of the stratified squamous epithelium. J Cell Biol (2002) 1.33
Gait alterations in healthy carriers of the LRRK2 G2019S mutation. Ann Neurol (2011) 1.29
Preimplantation aneuploid embryos undergo self-correction in correlation with their developmental potential. Fertil Steril (2008) 1.28
Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of the literature. Hum Mutat (2009) 1.18
Mice lacking neuronal nicotinic acetylcholine receptor beta4-subunit and mice lacking both alpha5- and beta4-subunits are highly resistant to nicotine-induced seizures. Physiol Genomics (2004) 1.17
Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn (2002) 1.08
Prenatal detection of congenital bilateral cataract leading to the diagnosis of Nance-Horan syndrome in the extended family. Prenat Diagn (2007) 1.06
Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk. Arch Neurol (2012) 1.05
Brachydactyly A-1 mutations restricted to the central region of the N-terminal active fragment of Indian Hedgehog. Eur J Hum Genet (2009) 1.04
Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum Mutat (2002) 1.03
Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit. J Physiol (2002) 1.03
Carrier testing for spinal muscular atrophy. Genet Med (2010) 1.02
Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol (2002) 1.02
Surgical treatment of craniofacial fibrous dysplasia in adults. Neurosurg Rev (2013) 1.02
Rett syndrome: clinical manifestations in males with MECP2 mutations. J Child Neurol (2002) 1.00
Genetic testing in Israel: an overview. Annu Rev Genomics Hum Genet (2009) 0.99
Elucidating the origin of chromosomal aberrations in IVF embryos by preimplantation genetic analysis. Mol Cell Endocrinol (2007) 0.98
Central role of fibroblast alpha3 nicotinic acetylcholine receptor in mediating cutaneous effects of nicotine. Lab Invest (2003) 0.98
Multiple supra- and infratentorial intraparenchymal hemorrhages presenting with seizure after massive sacral cerebrospinal fluid drainage. Spine (Phila Pa 1976) (2011) 0.97
Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors. Neoplasia (2006) 0.97
The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice. Prog Neurobiol (2002) 0.96
Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes. Eur J Neurosci (2010) 0.96
FGFR1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5' CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes. Genes Chromosomes Cancer (2007) 0.95
Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse. J Physiol (2004) 0.94
Screening for familial dysautonomia in Israel: evidence for higher carrier rate among Polish Ashkenazi Jews. Genet Test (2003) 0.94
Large-scale population screening for spinal muscular atrophy: clinical implications. Genet Med (2011) 0.94
Lower core body temperature and attenuated nicotine-induced hypothermic response in mice lacking the beta4 neuronal nicotinic acetylcholine receptor subunit. Brain Res Bull (2005) 0.94
The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews. J Neural Transm (Vienna) (2009) 0.93
Novel causative mutations in patients with Nance-Horan syndrome and altered localization of the mutant NHS-A protein isoform. Mol Vis (2008) 0.92
Clinical evaluation of isolated nonvisualized fetal gallbladder. Prenat Diagn (2007) 0.92
Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate. Neoplasia (2007) 0.91
Maternal serum HCG is higher in the presence of a female fetus as early as week 3 post-fertilization. Hum Reprod (2002) 0.91
Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011. Prenat Diagn (2011) 0.91
Human embryonic stem cells carrying mutations for severe genetic disorders. In Vitro Cell Dev Biol Anim (2010) 0.90
Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clin J Am Soc Nephrol (2014) 0.90
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers. Neurology (2012) 0.90
Current controversies in prenatal diagnosis 3: For prenatal diagnosis, should we offer less or more than metaphase karyotyping? Prenat Diagn (2009) 0.90
Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism. Brain (2012) 0.89
Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's disease. J Neurol Sci (2011) 0.89
A protocol for genetic evaluation of patients with multiple colorectal adenomas and without evidence of APC gene mutation. Isr Med Assoc J (2010) 0.89
Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations. Clin Endocrinol (Oxf) (2009) 0.88
Circulating angiogenic proteins in trisomy 13. Am J Obstet Gynecol (2006) 0.88
Preimplantation genetic diagnosis for fragile X syndrome using multiplex nested PCR. Reprod Biomed Online (2007) 0.87
The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction. J Mol Neurosci (2011) 0.87
Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors. Prostate (2009) 0.87
Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation. Mov Disord (2013) 0.87
Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res (2004) 0.87
Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans. Hum Mol Genet (2010) 0.87
Two novel translocations, t(2;4)(q35;q31) and t(X;12)(q22;q24), as the only karyotypic abnormalities in a malignant peripheral nerve sheath tumor of the skull base. Cancer Genet Cytogenet (2003) 0.87
Subunit composition of α5-containing nicotinic receptors in the rodent habenula. J Neurochem (2012) 0.86
2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome. Fetal Diagn Ther (2005) 0.86
Prospective randomized comparison of two embryo culture systems: P1 medium by Irvine Scientific and the Cook IVF Medium. J Assist Reprod Genet (2004) 0.86
Clopidogrel Resistance by P2Y12 Platelet Function Testing in Patients Undergoing Neuroendovascular Procedures: Incidence of Ischemic and Hemorrhagic Complications. J Vasc Interv Neurol (2013) 0.86
An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC. Fam Cancer (2010) 0.86
Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6. Prostate (2006) 0.85
Decompressive craniectomy after intra-arterial thrombolysis: safety and outcome. J Neurol Neurosurg Psychiatry (2010) 0.85
Increased sensitivity to nicotine-induced seizures in mice heterozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor. Neuroreport (2002) 0.85
The concept of a hybrid operating room: applications in cerebrovascular surgery. Acta Neurochir Suppl (2013) 0.85
Extracolonic manifestations of familial adenomatous polyposis after proctocolectomy. Arch Surg (2005) 0.85
Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. Life Sci (2003) 0.85
Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers. Cortex (2013) 0.85
An audit of familial juvenile polyposis at the Tel Aviv Medical Center: demographic, genetic and clinical features. Fam Cancer (2003) 0.84
Paternal deletion of the 11p15.5 centromeric-imprinting control region is associated with alteration of imprinted gene expression and recurrent severe intrauterine growth restriction. J Med Genet (2012) 0.84
HIF1A C1772T polymorphism leads to HIF-1α mRNA overexpression in prostate cancer patients. Cancer Biol Ther (2012) 0.83
Deficiency of nicotinic acetylcholine receptor beta 4 subunit causes autonomic cardiac and intestinal dysfunction. Mol Pharmacol (2003) 0.83
Insight into the intrinsic sensitivity of the PCR assay used to detect CMV infection in amniotic fluid specimens. J Clin Virol (2004) 0.83
MECP2 mutations in Israel: implications for molecular analysis, genetic counseling, and prenatal diagnosis in Rett syndrome. Hum Mutat (2002) 0.83
Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries. Neurogenetics (2009) 0.83
Differential brain transcriptome of beta4 nAChR subunit-deficient mice: is it the effect of the null mutation or the background strain? Physiol Genomics (2006) 0.83